Skip to main content
SEER
NASDAQ Industrial Applications And Services

Seer Q2 Revenue Drops 23% to $3.1M, but Loss Narrows to $16.9M; Cash Runway Holds at $209.5M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$2.13
Mkt Cap
$119.483M
52W Low
$1.55
52W High
$2.41
52W Position info
37% above low
Off High info
12% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

SEER sits 37% above its 52-week low of $1.55 on light trading volume (0.2× avg).

Summary

Seer reported Q2 2026 revenue of $3.1M, down 23% year-over-year, while net loss narrowed to $16.9M from $19.4M. Cash and investments stand at $209.5M, sufficient for at least 12 months. The company continues to repurchase shares and provided updates on patent litigation.


Key Events · Earnings and Guidance · SEER

  • Revenue Decline Continues

    Total revenue for Q2 2026 fell 23% year-over-year to $3.1M, driven by lower product and service sales. For the first half, revenue of $5.9M was down 29% from H1 2025.

  • Loss Narrows on Cost Cuts

    Net loss improved to $16.9M from $19.4M a year ago, as R&D spending dropped 32% and SG&A fell 5%. Operating cash burn was $25.0M for H1 2026.

  • Strong Liquidity Position

    Cash, equivalents, and investments totaled $209.5M at June 30, 2026, with management stating this is sufficient to fund operations for at least 12 months.

  • Share Repurchases Continue

    The company repurchased 202,979 shares in Q2 at an average price of $1.68, with $25.1M remaining under its $50M total authorization.


Analysis · SEER · Industrial Applications And Services

Seer's second-quarter results reflect a persistent revenue slide, yet aggressive cost-cutting has meaningfully narrowed losses. With $209.5M in cash and investments, the company has ample runway through at least mid-2027. Against the backdrop of an ongoing proxy contest with activist investors, the improved cash burn rate and maintained liquidity are critical survival signals. The filing also discloses new patent litigation developments and a small SAFE investment in PrognomiQ.

At the time of this filing, SEER was trading at $2.13 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $119.5M. The 52-week trading range was $1.55 to $2.41. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SEER - Latest Insights

SEER
Aug 11, 2026, 4:12 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.17
Real-time Price: $2.13 info
Change: -$0.040 (-2%) info
Market Cap: $119.483M info
SEER
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.15
Real-time Price: $2.13 info
Change: -$0.020 (-0.93%) info
Market Cap: $119.483M info
SEER
Jul 31, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.21
Real-time Price: $2.13 info
Change: -$0.080 (-4%) info
Market Cap: $119.483M info
SEER
Jul 31, 2026, 7:47 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.18
Real-time Price: $2.13 info
Change: -$0.050 (-2%) info
Market Cap: $119.483M info
SEER
Jul 30, 2026, 6:52 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.18
Real-time Price: $2.13 info
Change: -$0.050 (-2%) info
Market Cap: $119.483M info